Midodrine| CAS 42794-76-3

Cas No.:	42794-76-3
Chemical Name:	2-amino-N-2-(2,5-dimethoxyphenyl)-2-hydroxyethylacetamide
Synonyms:	MIDODRINE;Acetamide, 2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]- (9CI);2-Amino-N-(2,5-dimethoxy-β-hydroxyphenethyl)acetamide;(±)-Midodrine;2-amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)acetamide;Acetamide,2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]-;2-amino-N-2-(2,5-dimethoxyphenyl)-2-hydroxyethylacetamide;C07890;NCGC00178238-02;(+/-)-2-amino-n-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide;42794-76-3 (free base);RS)-N'-(beta-Hydroxy-2,5-dimethoxy-phenethyl)glycinamid;HY-12749;EN300-25893675;1-(2',5'-Dimethoxyphenyl)-2-glycinamidoethanol;EINECS (255-945-3);N-{2-[2,5-bis(methyloxy)phenyl]-2-hydroxyethyl}glycinamide;MIDODRINE [HSDB];PTKSEFOSCHHMPD-UHFFFAOYSA-N;NCGC00178238-01;CHEMBL1201212;CS-4688;HSDB 7854;midodrine;St 1085;Acetamide, 2-amino-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)-;BRD-A79981887-003-05-7;(+-)-2-amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide;KBio3_002650;DTXSID0023321;CHEBI:6933;MIDODRINE [WHO-DD];Midodrin;MIDODRINE [INN];KBioGR_000763;Midodrina [INN-Spanish];2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethylacetamide;Spectrum_001641;ACETAMIDE, 2-AMINO-N-(2-(2,5-DIMETHOXYPHENYL)-2-HYDROXYETHYL)-, (+/-)-;Prestwick0_000191;Midodrina (INN-Spanish);SBI-0051934.P002;AB00053715_08;BSPBio_000141;2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]ethanimidic acid;2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide;DL-N1-(beta-Hydroxy-2,5-dimethoxyphenethyl)glycinamid;EINECS 255-945-3;2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamide;BPBio1_000157;SPBio_002062;KBio2_007257;UNII-6YE7PBM15H;Midodrina;Midodrinum (INN-Latin);Midodrinum;2-Amino-N-(2,5-dimethoxy-beta-hydroxyphenethyl)acetamid;BRD-A79981887-003-09-9;KBio1_000955;DB00211;DivK1c_000955;Spectrum3_001585;AKOS015967099;Spectrum5_000962;IDI1_000955;NS00008914;DTXCID903321;KBio2_004689;Q415051;SCHEMBL20996761;FT-0740719;KBio2_002121;rac-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]glycinamide;Midodrine [INN:BAN];Midodrinum [INN-Latin];133163-28-7;BSPBio_003150;A913477;(RS)-N'-(beta-Hydroxy-2,5-dimethoxy-phenethyl)glycinamid;ST-1085;C01CA17;GTPL7240;SCHEMBL131436;MIDODRINE [MI];s5735;MIDODRINE [VANDF];D08220;Midodrine (INN);HMS3886M20;rac-N-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)glycinamide;ProAmatine;KBioSS_002121;AB00053715;Midodrine free base;Prestwick3_000191;Prestwick1_000191;Spectrum2_001545;42794-76-3;NINDS_000955;Spectrum4_000192;(+/-)-2-AMINO-N-(.BETA.-HYDROXY-2,5-DIMETHOXYPHENETHYL)ACETAMIDE;6YE7PBM15H;Prestwick2_000191;SPBio_001390;(±)-Midodrin
SMILES:	O=C(NCC(C1=CC(OC)=CC=C1OC)O)CN
Formula:	C₁₂H₁₈N₂O₄
M.Wt:	254.28232
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

Midodrine is a selective α1-adrenoceptor agonist that acts as a vasopressor/antihypotensive agent for the treatment of dysautonomia and orthostatic hypotension; activates the alpha-adrenergic receptors of the arteriolar and venous vasculature, producing an increase in vascular tone and elevation of blood pressure; does not stimulate cardiac beta-adrenergic receptors, and diffuses poorly across the blood-brain barrier.HypertensionApproved

MSDS

COA

LOT NO.	DOWNLOAD

2018-0101

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.